Dr. Reddy’s supplies high-quality APIs to leading formulation manufacturers across the world, enabling them to develop affordable medicines for patients worldwide. We are the preferred API partner to pharma companies across the US, Europe, Latin America, Japan, China, Korea and emerging markets. Our global establishment is rooted in deep technical strengths established over the last 38 years in the development and manufacture of complex APIs such as steroids, peptides, complex long-chain molecules, and highly potent APIs (HPAIs /oncology drugs). We have strong technical and cross-functional teams including R&D, Quality, Engineering & Analytical departments. Our dedicated R&D teams are committed to developing complex products to meet the evolving API needs in the GMP environment. Dr. Reddy's manufactures a wide range of pharmaceuticals in India and overseas. Our API manufacturing facilities are operated following cGMP (ICH Q7) and are regularly inspected by international regulatory authorities. We have eight commercial USFDA inspected production units, six in India and one in Mexico and the UK. Our APIs have regulatory filings available in major markets across the world. For more information, visit our website.